Literature DB >> 3151258

Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression.

L E Ostrowski1, J Finch, P Krieg, L Matrisian, G Patskan, J F O'Connell, J Phillips, T J Slaga, R Breathnach, G T Bowden.   

Abstract

We have reported that transin RNA, a 1.9-kb RNA coding for a novel, secreted proteinase, was overexpressed during the progression of benign mouse skin papillomas to malignant squamous cell carcinomas (SCCs) induced by a two-stage protocol (Proc Natl Acad Sci USA 83:9413, 1986). Recently a high degree of similarity has been demonstrated between rabbit stromelysin, a secreted metalloproteinase that degrades proteoglycans found in the basement membrane and the amino acid sequence predicted in rat transin cDNA. DNA sequencing of a mouse cDNA isolated from an SCC (initiated by 7,12-dimethylbenz[a]anthracene [DMBA] and promoted by 12-O-tetradecanoylphorbol-13-acetate [TPA]) showed greater than 85% nucleotide similarity and 90% amino acid similarity to the rat transin-1 cDNA nucleotide and predicted amino acid sequences. Using this mouse transin cDNA clone as a probe (labeled with 32P) we found enhanced levels of transin mRNA transcripts in SCCs induced by a protocol giving rise to metastatic tumors (repeated N-methyl-N-nitroso-N'-nitroguanidine [MNNG] treatments) compared with the level found in SCCs induced by a protocol that had a lower probability of giving rise to metastatic tumors (MNNG initiation followed by TPA promotion). A study of primary SCCs and metastatic lesions induced by repeated benzo[a]pyrene treatment showed that the levels of transin mRNA transcripts were reduced in the metastatic lesions in comparison to the primary tumors. Southern analysis of the DNA isolated from epidermis, papillomas, and SCCs indicated that neither transin gene amplification nor rearrangement accounted for increased levels of the transin mRNA transcripts. These data suggest a role for enhanced levels of transin production in the invasion and metastasis of chemically induced SCCs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3151258     DOI: 10.1002/mc.2940010106

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  23 in total

1.  Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases.

Authors:  S J Atkinson; R V Ward; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

Review 2.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

3.  Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C.

Authors:  S E McDonnell; L D Kerr; L M Matrisian
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors.

Authors:  D L Hulboy; L M Matrisian; H C Crawford
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Degradation of endothelial cell matrix collagen is correlated with induction of stromelysin by an activated ras oncogene.

Authors:  J E LoSardo; B S Goggin; O Bohoslawec; A Neri
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

Review 6.  Stromelysin in tumor progression and metastasis.

Authors:  S McDonnell; L M Matrisian
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

7.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

Review 8.  The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter.

Authors:  M D Sternlicht; M J Bissell; Z Werb
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

9.  Porcine splenic peptides (Polyerga) decrease the number of experimental lung metastases in mice.

Authors:  M Jurin; N Zarković; Z Ilić; S Borović; M Hartleb
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

10.  Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.

Authors:  J P Witty; J H Wright; L M Matrisian
Journal:  Mol Biol Cell       Date:  1995-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.